Healthcare >> Analyst Interviews >> January 17, 2000

Recent Advances In Biotechnology : Albert L. Rauch – First Union Securities

ALBERT L. RAUCH is a Senior Vice President of Health Care Technology with First Union Securities, having joined the firm as EVEREN Securities in 1996. Previously, he was associated with A.G. Edwards and Pfizer, Inc., where he served as a Senior Research Scientist in the Department of Metabolic Diseases. Dr. Rauch was a NIH postdoctoral fellow in the Department of Physiology and Pharmacology at the Wake Forest School of Medicine and was later on the faculty there. A Chartered Financial Analyst, he holds a Doctoral degree in Experimental Pathology from Emory University and an M.B.A. from the Rensselaer Polytechnic Institute. Profile
TWST: Tell us about some of the advances that have been made over the

last several years that have helped us gain a better understanding about

how the brain works, and the connection between the